Huang, Hsuan-Ying ,M.D.
Intitution: Kaohsiung Chang Gung Memorial Hospital/ Chang Gung University
Position: Director/Professor
Department: Anatomical Pathology
Address: 123 Ta-Pei Road, Niao-Sung, Kaohsiung, Taiwan
Tel: +886-7-7317123#2537 Fax: +886-7-7333198
E-mail: hyhuang@cgmh.org.tw
Focus of Interest:
Fulltime Employment:
Education:
Honors and Awards:
Board Certification:
Intitution: Kaohsiung Chang Gung Memorial Hospital/ Chang Gung University
Position: Director/Professor
Department: Anatomical Pathology
Address: 123 Ta-Pei Road, Niao-Sung, Kaohsiung, Taiwan
Tel: +886-7-7317123#2537 Fax: +886-7-7333198
E-mail: hyhuang@cgmh.org.tw
Focus of Interest:
- Oncology
- Orthopedics
- Pathology
- Surgery
Fulltime Employment:
- Jul 2010 ~ present Director of Anatomical Pathology, Kaohsiung Chang Gung Memorial Hospital
- Jul 2009 ~ Jun 2010 Associate Director of Anatomical Pathology, Kaohsiung Chang Gung Memorial Hospital
- Jul 2001 ~ Jun 2003 Research fellow of bone and soft tissue tumors Dep't of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
- Aug 1999 ~ Jun 2009 Staff Pathologist, Dep't of Anatomical Pathology Kaohsiung Chang Gung Memorial Hospital
- Jul 1995 ~ Jul 1999 Resident, Dep't of Anatomical Pathology Kaohsiung, Chang Gung Memorial Hospital
- Jan 1995 ~ Jun 1995 Resident, Dep't of Neurology Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan
Education:
- Sept. 1986 – June 1993 M.D., Kaohsiung Medical University School of Medicine, Kaohsiung, Taiwan
Honors and Awards:
- Senior grant proposal reviewers of national council of science – forensic medicine and pathology (2008, 2009, 2011, 2012, 2014)
- Senior member of editorial board: International Journal of Clinical and Experimental Pathology (SCI)
- Guest editor of Pathology Research International
- Educational member of molecular pathology committee of Taiwan Society of Pathology
- Consultant and study group convener of bone and soft tissue pathology of Taiwan Society of Pathology
- Concilor of Taiwan Society of Pathology
- Co-convener of the 7th (Taipei, Taiwan) and 8th (Busan, Korea) Asia-Pacific IAP congress, bone and soft tissue session
- Invited external reviewer: Journal: Pathology (SCI), Laryngoscope (SCI), Journal of Cellular Physiology (SCI), TOHOKU J EXP MED (SCI), BMC Cancer (SCI), Clinical Cancer Research (SCI), Cancer Research (SCI), Acta dermatologica Sinica Grant proposal: University College London Hospitals-NHS Foundation Trust
- WHO Classification of Tumours, Pathology &Genetics Tumours of Soft tissue and Bone: invited author for myxofibrosarcoma
- 2009 Wu Da-You memorial award endowed by Taiwan national council of science
- 2010 Yeh Su Foundation best paper award of the year endowed by Taiwan Society of Pathology
Selected Main Publications:
- Huang HY, Illei PB, Zhao Zq, Mazumdar M, Huvos AG, Healey JH, Wexler LH, Gorlick R, Meyers P, Ladanyi M. Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse J Clin Oncol 2005, 20;23(3):548-58. (SCI, 2013 IF: 17.879, rank: 5/202=2.5% in Oncology)
- Li CF, Huang WW, Wu JM, Yu SC, Hu TH, Uen YH, Tian YF, Lin CN, Lu D, Fang FM, Huang HY*. Heat Shock Protein 90 Overexpression Independently Predicts Inferior Disease-free Survival with Differential Expression of the α and β Isoforms in Gastrointestinal Stromal Tumors. Clinical Cancer Research 2008, Dec 1; 14(23):7822-31. (SCI 2013 IF: 8.193, rank, 13/202=6.4 % in Oncology, corresponding author, NSC 95-2320-B-182A-007 -MY2, 98年台灣病理學會-葉曙基金會最佳論文)
- Huang HY, Li SH, Yu SC, Chou FF, Tzeng CC, Hu TH, Uen YH, Tian YF, Wang YH, Fang FM, Huang WW, Wei YC, Wu JM, Li CF*. Homozygous Deletion of MTAP gene as a Poor Prognosticator in Gastrointestinal Stromal Tumors. Clinical Cancer Research 2009; 15(22): 6963-72. (SCI 2013 IF: 8.193, rank, 13/202=6.4 % in Oncology, NSC 94-2320-B-182A-005, NSC 95-2320-B-182A-007 -MY2, CMRPG850442, 99年台灣病理學會-葉曙基金會最佳論文)
- Huang HY, Wu WR, Wang YH, Wang JW, Fang FM, Tsai JW, Li SH, Hung HC, Yu SC, Lan J, Shiue YL, Hsing CH, Chen LT, Li CF. ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: aberrant loss via epigenetic DNA methylation confers aggressive phenotypes, negative prognostic impact, and therapeutic relevance. Clinical Cancer Research 2013 Jun 1;19(11):2861-2872. (SCI 2013 IF: 8.193, rank, 13/202=6.4 %in Oncology)
- Li CF, Fang FM, J Lan, JW Wang, Kung HJ, Chen LT, TJ Chen, Li SH, Wang YW, HC Tai, Yu SC, HY Huang*. AMACR amplification in myxofibrosarcomas: a mechanism of overexpression that promotes cell proliferation with therapeutic relevance. Clinical Cancer Research (SCI in press, 2013 IF: 8.193, rank, 13/202=6.4 % in Oncology)
All Publications List
Board Certification:
- Diploma of the Board of Pathology in Anatomic Pathology No. 0263